PHG NYSE Week ended 31 Jul 2026

Weekly Investor Report

Koninklijke Philips NV ADR · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 26.30 USD
0.5% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -3.4% below the Trend Line and sits at 29.5% of its 52-week range. The latest completed week returned 0.5%, after a -5.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bearish with 60/100 conviction, while the latest news-sentiment score is 51/100.

Setup score 51 out of 100
Latest Close 26.30 USD 31 Jul 2026
1W Return 0.5% latest completed week
4W Return -5.2% short-term follow-through
12W Return 0.5% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio 2.3x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
  • Next-week expectancy is positive at 56.45% based on similar historical setup states.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.5% Latest completed week; four-week move -5.2%. Indicator stack 32/69 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 56.45% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bearish 60/100 conviction; expected move 5.0%. News sentiment 51/100 69 relevant articles in the latest sentiment read. Event risk 28 Jul Latest stored earnings date was 28 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -3.4% below the Trend Line and sits at 29.5% of its 52-week range. The latest completed week returned 0.5%, after a -5.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.3x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2712-week average 0.20

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.27Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -5.2% over four weeks, 0.5% over 12 weeks, and 3.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.5%
4W-5.2%
12W0.5%
26W-4.7%
52W3.3%
Active trend streak0 weeks
Active weeks in one year30
Trend breadth57.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.11Latest activity-pressure read.
Pressure change218.7%Four-week change in activity pressure.
Leadership-10.48Latest relative-leadership reading.
RS change-76.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 02 Aug 2026 Financial statements through 30 Jun 2026 Field coverage 97% Model confidence 97%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength71/100Blend of value, momentum, and quality. Underlying universe rank 30; rank 1 is best.
Value70/100Relative valuation strength. Underlying universe rank 31; rank 1 is best.
Quality79/100Profitability and accounting quality. Underlying universe rank 22; rank 1 is best.
Momentum20/100Medium-term price momentum. Underlying universe rank 81; rank 1 is best.
Growth30/100Revenue and earnings growth. Underlying universe rank 71; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework64/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
23.1x
Price divided by trailing earnings.
Price / sales
1.5x
Market value relative to trailing revenue.
EV / EBITDA
10.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
8.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
45.9%
Gross profit retained from each unit of revenue.
Operating margin
10.3%
Operating profit retained from revenue.
Free-cash-flow margin
15.1%
Free cash flow generated from revenue.
Return on invested capital
8.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-1.1%
Latest one-year revenue growth.
EPS growth
587.7%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
49.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
3.9%
Cash dividends relative to market value.
Buyback yield
-0.1%
Net share repurchases relative to market value.
Shareholder yield
3.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

PHG shows bearish options pressure with a 60/100 conviction score, put-call volume ratio of 6.88, expected move of 5.0%, and Sharemaestro trend signal inactive.

Conviction60/100
Expected move5.0%
Put/call volume6.88
Pressure-69
Speculation40
Volatility39
Trend agreement68
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 69 relevant articles.

14 positive · 48 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings28 JulLatest stored earnings date was 28 Jul 2026.
Options expected move5.0%Nearest-chain priced movement where available.
52-week drawdown-18.2%Distance below the 52-week high.
13-week volatility2.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+6.8%Week of 22 May.
Worst week-9.6%Week of 6 Mar.
Latest week+0.5%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains10
Flat weeks0
Modest losses7
Sharp losses4
Recent vol2.8%13-week weekly-return volatility.
Base vol3.7%52-week weekly-return volatility.
Up/down split29/22Count of positive and negative weeks in the 52-week window.
Average skew2.7% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape51/100

Trend, activity pressure, participation, and risk combine to a 51/100 tape read.

 Indicator analysis22/100

Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.

Activity pressure 0.27; No reversal markers Next-Week ExpectancyPositive 56.45%

Next-week expectancy is positive with a 56.45% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors61/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 72 SVQF64/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 364.0 of 1014 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options40/100

PHG shows bearish options pressure with a 60/100 conviction score, put-call volume ratio of 6.88, expected move of 5.0%, and Sharemaestro trend signal inactive.

Bearish · Put-side pressure · Expected move 5.0% Sentiment51/100

Weighted news tone is neutral across 69 relevant articles.

Philips (ENXTAM:PHIA) Reports Strong Q2 Growth And Raises Full Year Outlook Insiders50/100

No recent insider transaction evidence is stored.

 Earnings28 Jul

Latest stored earnings date was 28 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202626.30 USD0.5%27.23 USD24.21 USD0.11-10.4814.1MOff
24 Jul 202626.17 USD-2.9%27.22 USD24.16 USD0.07-10.214.1MOff
17 Jul 202626.95 USD-1.6%27.22 USD24.12 USD0.25-8.284.8MOff
10 Jul 202627.40 USD-1.2%27.17 USD24.08 USD0.17-8.284.3MOff
3 Jul 202627.74 USD2.4%27.11 USD24.04 USD0.03-5.923.6MOff
26 Jun 202627.10 USD1.2%27.06 USD23.99 USD-0.19-6.124.9MOff
19 Jun 202626.78 USD1.2%27.06 USD23.95 USD-0.47-9.484.7MOff
12 Jun 202626.46 USD1.3%27.04 USD23.90 USD-0.55-9.755.9MOff
5 Jun 202626.11 USD-1.1%27.08 USD23.85 USD-0.68-10.507.1MOff
29 May 202626.39 USD-2.1%27.11 USD23.80 USD-0.66-11.924.3MOff
22 May 202626.95 USD6.8%27.10 USD23.74 USD-0.64-8.885.8MOff
15 May 202625.23 USD-3.6%27.13 USD23.69 USD-0.74-14.036.6MOff
8 May 202626.18 USD4.0%27.20 USD23.64 USD-0.64-10.848.3MOff
1 May 202625.17 USD-4.8%27.21 USD23.60 USD-0.67-12.497.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.